- Report
- April 2018
Global
From €961EUR$1,000USD£821GBP
- Drug Pipelines
- March 2021
Global
From €1922EUR$2,000USD£1,643GBP
- Drug Pipelines
- July 2020
- 50 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- April 2023
- 95 Pages
Global
€3363EUR$3,500USD£2,875GBP
- Report
- April 2023
- 46 Pages
Global
From €4799EUR$4,995USD£4,103GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €480EUR$500USD£411GBP
- Report
- January 2019
- 35 Pages
Global
From €961EUR$1,000USD£821GBP
- Report
- April 2023
- 71 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- February 2023
- 81 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- January 2023
- 210 Pages
Global
From €5506EUR$5,730USD£4,707GBP
- Report
- October 2022
- 215 Pages
Global
From €5506EUR$5,730USD£4,707GBP
- Report
- April 2024
- 160 Pages
From €5764EUR$5,999USD£4,928GBP
- Report
- April 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
Botox is a brand name of a neurotoxin produced by the bacterium Clostridium botulinum. It is used to treat a variety of medical conditions, including muscle spasms, excessive sweating, and chronic migraines. Botox is also used cosmetically to reduce the appearance of wrinkles. It is a part of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders, such as epilepsy, Parkinson's disease, and multiple sclerosis.
The Central Nervous System Drugs market is highly competitive, with many companies offering similar products. Companies in the Botox market include Allergan, Merz, Ipsen, Revance Therapeutics, and Galderma. Allergan is the largest producer of Botox, with a wide range of products and services. Merz is a German-based company that produces a range of neurotoxins, including Botox. Ipsen is a French-based company that produces a range of products, including Botox. Revance Therapeutics is a US-based company that produces a range of products, including Botox. Galderma is a Swiss-based company that produces a range of products, including Botox. Show Less Read more